BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8422465)

  • 21. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
    Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
    Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid.
    Lutz PG; Houzel-Charavel A; Moog-Lutz C; Cayre YE
    Blood; 2001 Apr; 97(8):2449-56. PubMed ID: 11290610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteome and transcriptome analysis of retinoic acid-induced differentiation of human acute promyelocytic leukemia cells, NB4.
    Wang D; Jensen R; Gendeh G; Williams K; Pallavicini MG
    J Proteome Res; 2004; 3(3):627-35. PubMed ID: 15253446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
    Duprez E; Wagner K; Koch H; Tenen DG
    EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferons induce normal and aberrant retinoic-acid receptors type alpha in acute promyelocytic leukemia cells: potentiation of the induction of retinoid-dependent differentiation markers.
    Gianní M; Zanotta S; Terao M; Rambaldi A; Garattini E
    Int J Cancer; 1996 Sep; 68(1):75-83. PubMed ID: 8895544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells.
    Sun J; Huang H; Zhu Y; Lan J; Li J; Lai X; Yu J
    Int J Hematol; 2005 Oct; 82(3):215-23. PubMed ID: 16207594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells.
    Bocchia M; Xu Q; Wesley U; Xu Y; Korontsvit T; Loganzo F; Albino AP; Scheinberg DA
    Leuk Res; 1997 May; 21(5):439-47. PubMed ID: 9225073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
    Duprez E; Lillehaug JR; Gaub MP; Lanotte M
    Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
    Herwig S; Su Q; Zhang W; Ma Y; Tempst P
    Blood; 1996 Jan; 87(1):350-64. PubMed ID: 8547662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
    Nason-Burchenal K; Allopenna J; Bègue A; Stéhelin D; Dmitrovsky E; Martin P
    Blood; 1998 Sep; 92(5):1758-67. PubMed ID: 9716606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells.
    Ikezoe T; Daar ES; Hisatake J; Taguchi H; Koeffler HP
    Blood; 2000 Nov; 96(10):3553-9. PubMed ID: 11071654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.
    Gianní M; Li Calzi M; Terao M; Guiso G; Caccia S; Barbui T; Rambaldi A; Garattini E
    Blood; 1996 Feb; 87(4):1520-31. PubMed ID: 8608243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.
    Moog-Lutz C; Peterson EJ; Lutz PG; Eliason S; Cavé-Riant F; Singer A; Di Gioia Y; Dmowski S; Kamens J; Cayre YE; Koretzky G
    J Biol Chem; 2001 Jun; 276(25):22375-81. PubMed ID: 11301322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2.
    Grolleau A; Wietzerbin J; Beretta L
    Leukemia; 2000 Nov; 14(11):1909-14. PubMed ID: 11069026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia.
    Burchert A; Wölfl S; Schmidt M; Brendel C; Denecke B; Cai D; Odyvanova L; Lahaye T; Müller MC; Berg T; Gschaidmeier H; Wittig B; Hehlmann R; Hochhaus A; Neubauer A
    Blood; 2003 Jan; 101(1):259-64. PubMed ID: 12393722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.
    Walsby EJ; Gilkes AF; Tonks A; Darley RL; Mills KI
    Br J Haematol; 2007 Oct; 139(1):94-7. PubMed ID: 17854312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
    Falanga A; Consonni R; Marchetti M; Locatelli G; Garattini E; Passerini CG; Gordon SG; Barbui T
    Blood; 1998 Jul; 92(1):143-51. PubMed ID: 9639510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.